Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 48Leukemia 41Breast Neoplasms 28Lymphoma 21Leukemia, Myeloid, Acute 16Burkitt Lymphoma 13Myelodysplastic Syndromes 11Graft vs Host Disease 10Lymphoma, Non-Hodgkin 7Lymphoma, Large B-Cell, Diffuse 7Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7Leukemia, Biphenotypic, Acute 7Squamous Cell Carcinoma of Head and Neck 6Urinary Bladder Neoplasms 5Leukemia, Promyelocytic, Acute 5Hodgkin Disease 5Anemia, Refractory, with Excess of Blasts 5Osteosarcoma 4Myeloproliferative Disorders 4Lymphoma, Follicular 4Leukemia, Myelomonocytic, Chronic 4Head and Neck Neoplasms 4Arthritis, Rheumatoid 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, Large-Cell, Anaplastic 3Leukemia, Myeloid, Chronic-Phase 3Leukemia, Myeloid, Accelerated Phase 3Leukemia, Lymphocytic, Chronic, B-Cell 3

Interventions

Radiotherapy, Intensity-Modulated 2Docetaxel 2Chemotherapy, Adjuvant 2dehydroftorafur 1cevimeline 1Radiotherapy, Conformal 1Radiotherapy 1Platinum 1Paclitaxel 1Methotrexate 1Immunoglobulin G 1Hypericum extract LI 160 1Fluorouracil 1Fentanyl 1Doxepin 1Disulfides 1Cisplatin 1Carboplatin 1Brachytherapy 1Bevacizumab 1Acupuncture Therapy 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Salivary Gland Neoplasms × Methotrexate × Clear all
NCT00003592 2023-06-22

Methotrexate Compared With Paclitaxel in Treating Patients With Advanced Head and Neck Cancer

Eastern Cooperative Oncology Group

Phase 3 Completed
230 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Salivary Gland Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡